Outcomes in Adhesive Small Bowel Obstruction from a Large Statewide Database: What to Expect after Non-Operative Management.
Although adhesive small bowel obstruction (ASBO) is frequently managed non-operatively, little is known regarding outcomes on readmission following this approach. Using a large population-based dataset, we evaluated risk factors for operative intervention and mortality at readmission in patients with ASBO who were initially managed non-operatively. ASBO patients were identified in the California Office of Statewide Health Planning and Development 2007-2014 patient discharge database. Patients who were managed operatively at index admission or had an ICD-9-CM diagnosis code for non-adhesive obstructive small bowel disease were excluded. Associations between risk factors and both operative intervention and death following readmission were evaluated using survival analysis. Among 15,963 ASBO patients, 3,103 (19.4%) had at least one readmission. The 1,069 (34.5%) who received an operation during their first readmission presented sooner (175 days versus 316 days, p<0.001) and were more likely to die during that readmission (5.2% versus 0.7%, p<0.001). Operative management at first readmission was associated with younger age, fewer comorbidities, and shorter times to readmission. Patients operatively managed at first readmission had longer times to second readmission compared with non-operative patients.Stratified analyses using non-operative patients as the reference over the study period revealed that patients who underwent lysis of adhesions and bowel resection were 5.04 times (95% Confidence Interval [CI] 2.82- 9.00) as likely to die while those who underwent lysis only were 2.09 times (95%CI 1.14 - 3.85) as likely to die. Patients with bowel resection only were at an increased risk for subsequent interventions beyond the first readmission (Hazard Ratio 1.79, 95%CI 1.11 - 2.87). In a large cohort readmitted for ASBO and initially managed non-operatively, subsequent operative intervention conferred a greater risk of death and a longer time to readmission among survivors. Prospective research is needed to further delineate outcomes associated with initial non-operative management of ASBO. Level III. Prognostic and Epidemiological.